Characterization of aspartokinase double mutants using a combination of experiments and simulations.

Aspartokinase Double mutant MD MST Mechanism Site-directed mutation

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 06 08 2022
revised: 14 01 2023
accepted: 18 01 2023
pubmed: 8 2 2023
medline: 8 2 2023
entrez: 7 2 2023
Statut: epublish

Résumé

Aspartokinase (AK) is synergistically suppressed by Thr and Lys in the

Identifiants

pubmed: 36747545
doi: 10.1016/j.heliyon.2023.e13133
pii: S2405-8440(23)00340-7
pmc: PMC9898291
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e13133

Informations de copyright

© 2023 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Int J Biol Macromol. 2018 Jun;112:1272-1277
pubmed: 29454953
Biotechnol Biofuels. 2018 Mar 22;11:76
pubmed: 29588661
J Biol Chem. 2010 Aug 27;285(35):27477-27486
pubmed: 20573952
J Mol Biol. 2007 Apr 27;368(2):521-36
pubmed: 17350037
Biochem J. 2018 Mar 20;475(6):1107-1119
pubmed: 29382741
Biotechnol Lett. 2020 Mar;42(3):429-436
pubmed: 31865476
Molecules. 2018 Dec 19;23(12):
pubmed: 30572676
Molecules. 2021 Dec 26;27(1):
pubmed: 35011350
J Mol Biol. 2010 Jun 4;399(2):283-93
pubmed: 20398676
Appl Microbiol Biotechnol. 2021 Sep;105(18):6899-6908
pubmed: 34455479
Appl Microbiol Biotechnol. 2021 Dec;105(24):9153-9166
pubmed: 34837493
Enzyme Microb Technol. 2019 Jun;125:6-12
pubmed: 30885326
FEBS J. 2009 Jun;276(11):3124-36
pubmed: 19490113
Bioprocess Biosyst Eng. 2022 Mar;45(3):541-551
pubmed: 35066675
Synth Syst Biotechnol. 2021 Sep 20;6(4):302-325
pubmed: 34632124
RSC Adv. 2020 Dec 22;11(1):30-38
pubmed: 35423034
RSC Adv. 2021 Apr 19;11(24):14527-14533
pubmed: 35424015
Biotechnol Rep (Amst). 2014 Sep 1;3:73-85
pubmed: 25170437
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Mar 1;67(Pt 3):380-5
pubmed: 21393848

Auteurs

Zhijie Chen (Z)

School of Pharmaceutical Sciences, Tsinghua University, 100084, Beijing, China.

Yu Fu (Y)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Shimeng Liu (S)

Jiaxing Xinbeilai Biotechnology Co., Ltd, China.

Xinyu Huang (X)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Xiaoting Kong (X)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Zhaojie Mao (Z)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Ning Hu (N)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Fengxiang Zhang (F)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Caijing Han (C)

School of Public Health, Weifang Medical University, Weifang, 261053, Shandong, China.

Classifications MeSH